Neil E. Fleshner, MD, MPH, FRCS, explains the basic science of High Intensity Focused Ultrasound (HIFU) for prostate cancer and currently available systems such as the Sonoblate and the Ablatherm. He emphasizes the importance of using this method safely, describing proper patient selection and post HIFU care.Read More
Neil E. Fleshner, MD, MPH, FRCSC
University of Toronto
Toronto, ON, Canada
Dr. Fleshner, MD, is a surgeon and clinician scientist and an established leader in the field of cancer prevention. He holds the Martin Barkin Chair, Division of Urology at the University of Toronto, and is a Professor in the Department of Surgery at the same University. Additionally, he is a staff member in the Division of Urology at the University Health Network and Princess Margaret Hospital in Toronto, Canada, and holds the Love Chair in Prostate Cancer Prevention at the Princess Margaret Hospital. Dr. Fleshner earned his MPH degree from the School of Public Health at Columbia University and completed his oncology training at Memorial Sloan Kettering Cancer Center. He has achieved international reputation as a talented cancer researcher who has made significant contributions in the field of urologic oncology. His current research priorities include translational, clinical, and health services research, focused primarily on understanding of prostate cancer pathogenesis, progression, and prevention. In addition to his clinical, academic, and research commitments, he heads the University Health Network GU BioBank, a central data and specimen repository designed to support the use of biological fluids in disease discovery, prognostication, and management. He has authored over 450 scientific papers and is a sought after speaker, both locally and internationally.